Fig. 2From: Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinomaGermline FH mutation frequency of PRCC2 in TCGA cohort (A). Common pathologic variants and corresponding mRNA expression in sPRCC2 (B). Data composition of two data sets including GES26574 and GSE48352 (C-D). Veen diagrams of common down-regulated genes and common up-regulated genes in sPRCC2 (E–F)Back to article page